Has Regeneron Stock Quietly Become A Value Buy?

REGN stock is presently trading nearly 38% lower than its 1-year peak, and is also being traded at a P/S multiple that is ...
The Cornell Daily Sun

Regeneron CEO Leonard Schleifer ’73 Involved in Trump Experimental COVID-19 Treatment

After news broke last weekend that President Donald Trump tested positive for COVID-19, Regeneron CEO Leonard Schleifer ’73 was once again thrust into the spotlight, running the biotech company ...
Reuters

Regeneron says Roche successfully tested manufacture of COVID-19 drug used on Trump

Nov 17 (Reuters) - Roche Holding AG (ROG.S), opens new tab has completed early tests of its ability to produce large quantities of Regeneron Pharmaceuticals Inc's (REGN.O), opens new tab COVID-19 ...
Reuters

Trump says he is pushing to get Regeneron's COVID-19 treatment approved quickly

WASHINGTON, Oct 9 (Reuters) - U.S. President Donald Trump said on Friday he is working to get coronavirus antibody drugs developed by Regeneron Pharmaceuticals Inc and Eli Lilly and Co approved ...